Preliminary scientific studies indicate conolidine could inhibit precise ion channels, decreasing neuronal excitability and limiting pain alerts. This system is particularly applicable in neuropathic soreness, where abnormal signaling results in persistent discomfort. Moreover, conolidine seems to influence G protein-coupled receptor (GPCR) pathway